Shenzhen, China Clinical Trials

INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use

INTERSTELLAR study will generate critical prospective real-world evidence on the benefits of adding Anifrolumab to standard of care treatment for SLE in routine clinical practice, to inform physicians, payers and patients. The study will use clinical assessments that are relevant for SLE-treating physicians in routine clinical practice, as well as …